Anxiety. Acute stress reaction
Conditions
Interventions
Intervention 1: In the intervention group, at the same time, the patient was put on headphones to listen to music and nature images on the screen via video projector, ten minutes before the start to t
In the intervention group, at the same time, the patient was put on headphones to listen to music and nature images on the screen via video projector, ten minutes before the start to the end of Bronch
Sponsors
Zahedan University of Medical Science
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: participants should: be between 20 to 60 years old; have the ability of speaking and Persian language understanding; be conscious and health on their hearings and visions; be undergoing bronchoscopy for the first time. Exclusion criteria: have background of severe psychological problems; have a severe symptoms (pain, cough and dyspnea) caused by respiratory diseases (asthma, lung cancer, etc); use the strong sedative or narcotic before bronchoscopy; be under treatment with corticosteroids (systemic or inhalation); have the emergency indication bronchoscopy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Before the start Bronchoscopy, ten minute after finishing Bronchoscopy. Method of measurement: The Spielberger State-Trait Anxiety Inventory (STAI).;Tolerance. Timepoint: Before the start Bronchoscopy, ten minute after finishing Bronchoscopy. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic and Diastolic Blood Pressure. Timepoint: Before start Bronchoscopy, every three minutes (after the third, sixth and ninth) during bronchoscopy, ten minutes after finishing bronchoscopy. Method of measurement: Mobile Vital Signs Monitoring Device.;Pulse Rate. Timepoint: Before start bronchoscopy, every three minutes (after the third, sixth and ninth) during bronchoscopy, ten minutes after finishing bronchoscopy. Method of measurement: Mobile Vital Signs Monitoring Device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahla Soleymani
Zahedan University of Medical Science, School of Nursing & Midwifery
Outcome results
None listed